BLNP 002
Alternative Names: BLNP-002Latest Information Update: 28 Feb 2021
Price :
$50 *
At a glance
- Originator BL-&-H
- Class Antidotes
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Poisoning
Most Recent Events
- 28 Feb 2021 No recent reports of development identified for clinical-Phase-Unknown development in Poisoning in South Korea
- 20 Feb 2019 BLNP 002 is still in clinical development for Poisoning in South Korea (BL & H pipeline, February 2019)
- 03 Sep 2015 Clinical trials in Poisoning in South Korea (unspecified route) before September 2015